The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of class III beta tubulin to predict efficacy from paclitaxel- or docetaxel-based chemotherapy in patients with advanced gastric cancer.
Jung Ryun Ahn
Disclosure not yet available
Minkyu Jung
Disclosure not yet available
Hyun Chang
Disclosure not yet available
Xianglan Zhang
Disclosure not yet available
Hei-Cheul Jeung
Disclosure not yet available
Tae Soo Kim
Disclosure not yet available
Jae Kyung Roh
Disclosure not yet available
Hyun Cheol Chung
Disclosure not yet available
Sun Young Rha
Disclosure not yet available